NCT04725981

Brief Summary

Comparing two surgical techniques in relation to vaginal stump infection, analysis of patient-based and therapy-based risk factors.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
141

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 23, 2018

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

December 8, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 27, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

October 13, 2022

Status Verified

October 1, 2022

Enrollment Period

4.1 years

First QC Date

December 8, 2020

Last Update Submit

October 11, 2022

Conditions

Keywords

vaginal closure technique

Outcome Measures

Primary Outcomes (1)

  • Number of participants with vaginal stump infection in intervention group and control group

    7.-10. day and 6 weeks postoperatively: 1. T ° C (fever\> = 38 ° C) 2. blood pressure (mm Hg) 3. general condition (good, reduced, bad) 4. Speculum examination / condition of the colpotomy: * non-irritating / intact * dehiscent * bleeding * fibrin-coated * purulent * tender * hyperemic * Infiltrated * Fistula formation 5. Lower abdominal pain (Visual Analog Scale (VAS): 0-10 6. transvaginal sonography: encapsulated RF on vaginal stump J: ☐N: ☐ 7. Laboratory CRP (\> 10mg / L) Hb (\<120 g / L) Lc ( \>10 G / L) The diagnosis of vaginal stump infection was made based on 2 of 3 positive clinical symptoms, 1 additional criterion and the corresponding sonographic findings. I. Clinical symptoms: 1. Fever\> = 38 ° C; 2. Dolence, redness, swelling, pus in the colpotomy area; 3. Lower abdominal pain ( VAS \>5) II. Sonographic signs (TVUS): encapsulated cystic mass on the vaginal stump Additional criteria: 1. CRP increased (\> 10mg / l); 2. Antibiotic therapy needs

    6 weeks

Secondary Outcomes (1)

  • Identify of patient-based and treatment-based risk factors for vaginal stump infection.

    6 weeks

Study Arms (2)

Arm A (test surgical technique)

EXPERIMENTAL

Colpotomy closure technique: 3 Z-suture with PDS 0 and 1 continuous suture with V-Loc 2-0

Procedure: Total laparoscopic hysterectomy

Arm B (control surgical technique)

ACTIVE COMPARATOR

Colpotomy closure technique: 3 Z-suture with PDS 0

Procedure: Total laparoscopic hysterectomy

Interventions

Control group: colpotomy closure technique: 3 Z-sutures PDS 0 Intervention group: colpotomy closure technique: 3 Z sutures with PDS 0 and 1 continuous suture with V-Loc 2-0

Arm A (test surgical technique)Arm B (control surgical technique)

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAll patients\> 18 years of age with an indication for total laparoscopic or robot-assisted hysterectomy (with or without adnexa / tubes) for benign uterine diseases.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient \> = 18 years old
  • Indication for total laparoscopic or robot-assisted hysterectomy
  • Benign uterine disease
  • Signed informed consent for study participation

You may not qualify if:

  • Patient with malignant gynecological diseases
  • Combination with other abdominal / vaginal interventions, except:
  • Adhesiolysis
  • Endometriosis removal (without rectovaginal endometriosis)
  • Conization
  • Hysteroscopy / curettage
  • Immunosuppressive therapy with cytostatics, glucocorticoids, HIV
  • Bleeding tendency / haemophilia
  • Acute infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spital Limmattal

Schlieren, Canton of Zurich, 8952, Switzerland

Location

MeSH Terms

Conditions

Vaginitis

Condition Hierarchy (Ancestors)

Vaginal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Tatiana Naydina Ragaz

    Tatiana Naydina Ragaz, Deputy Senior Gynecologist Women's Clinic, Spital Limmattal, Zurich Schlieren

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Compare two surgical techniques Prospective randomized, controlled, single-blind inversion study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Gynecologist in Women's Clinic

Study Record Dates

First Submitted

December 8, 2020

First Posted

January 27, 2021

Study Start

August 23, 2018

Primary Completion

September 30, 2022

Study Completion

September 30, 2022

Last Updated

October 13, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations